New cellular therapy offers hope for multiple myeloma patients
UChicago Medicine is the first program in Chicago to offer Abecma, a cell-based gene therapy for patients with treatment-resistant multiple myeloma.
A more comfortable mammogram? Yes, plus other new state-of-the-art breast cancer screening tools
UChicago Medicine is expanding and improving its breast cancer screening services, adding technology to make testing faster, easier and more comfortable.
Low-dose, four-drug combo blocks cancer's spread in mice
A new approach to preventing cancer spread that uses a combination of low-dose, metastasis-inhibiting drugs shows promise in mouse studies and may help prevent drug resistance or relapse.
